InvestorsHub Logo
icon url

Jockimo

07/30/15 10:02 PM

#9999 RE: Jockimo #9997

See Q3 data mention here from Missling.

http://act-ad.org/resources/q-anavex/

"The Phase 2a trial is a very exciting step. We dosed the first Alzheimer’s patient recently in January. The Company is looking forward to getting full trial data late this year, hopefully by third quarter of 2015."
icon url

edge

07/30/15 10:12 PM

#10001 RE: Jockimo #9997

Anavex and Missling are sandbagging, under promising and over delivering................love that redeeming quality in a company and a CEO.